Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Feb 2, 2011

Caliper Launches New Sciclone Automation Protocols for Illumina Sample Prep Kits

Caliper Launches New Sciclone Automation Protocols for Illumina Sample Prep Kits

New solutions are expected help mitigate bottlenecks in sample prep for next-generation sequencing. [Dmitry Sunagatov - Fotolia.com]

  • Caliper Life Sciences announced the availability of automation protocols on its Sciclone® NGS Workstation for Illumina’s TruSeq™ DNA and TruSeq RNA sample preparation kits.  “Caliper has responded to our customers’ requests for automated solutions to mitigate the bottlenecks in sample preparation for next-generation sequencing that resulted from the significant capacity of the HiSeq™ 2000 and SOLiD 5500 platforms,” comments Kevin Hrusovsky, Caliper’s president and CEO.

    "The Sciclone NGS Workstation is an open platform that was designed in collaboration with our external partners to accommodate the rapidly changing protocol requirements of the NGS market, including modifications for single-molecule sequencing workflows.”

    The firm says it has in addition developed automation protocols for Illumina’s standard library preparation kits and for Agilent’s SureSelect™ Target Enrichment kits, Nimblegen’s SeqCap™ EZ Human Exome Library v2.0, and ABI’s SOLiD™ Sequencing Chemistry. Last week Caliper announced a a co-marketing agreement with NuGEN to automate the latter’s Ovation® and Encore™ reagent solutions on Caliper’s liquid-handling platforms.



Related content

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »